| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.0M | +2.3% | +22.6% |
| Cost of Revenue | $14.8M | -7.0% | -8.6% |
| Gross Profit | $55.2M | +5.1% | +34.9% |
| R&D Expense | $13.7M | +27.8% | +68.1% |
| SG&A Expense | $12.0M | -8.8% | -5.8% |
| Operating Income | $7.5M | +102.6% | +1913.4% |
| Pre-tax Income | $8.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $179.2M | +2.3% | — |
| Accounts Receivable | $57.7M | -6.5% | — |
| Current Assets | $254.2M | -0.7% | — |
| Total Assets | $335.9M | -0.3% | — |
| Current Liabilities | $62.9M | -19.5% | — |
| Total Liabilities | $69.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.9M | — | — |
| Investing Cash Flow | -$18.8M | — | — |
| Financing Cash Flow | $88.5M | — | — |
| +134.6% |
| +319.1% |
| Income Tax | $1.9M | -2.0% | +3255.2% |
| Net Income | $6.4M | +124.5% | +265.7% |
| EPS (Basic) | $0.09 | +113.8% | +132.1% |
| EPS (Diluted) | $0.08 | +112.3% | +128.6% |
| -29.5% |
| — |
| Stockholders' Equity | $266.7M | +11.6% | +339.6% |